Reagent Portfolio - Coronavirus

About Mission Trail Biolabs

Mission Trail BioLabs is a private, early-revenue company founded in 2019 that operates as a reagent and contract service provider in the diagnostics and life sciences research sector. The company leverages expertise in protein expression and purification to supply critical research tools for infectious diseases, positioning itself as a niche supplier to academic and biopharma researchers. Its business model combines product sales of recombinant proteins with fee-for-service analytical work, targeting the urgent need for tools to combat antimicrobial resistance. While small, the company demonstrates a clear focus on global health challenges within a well-defined market segment.

Therapeutic Areas

Other Infectious Disease Research Drugs